Efficacy of iron dextran in parenteral nutrient solutions
Ali, M.; Kasper, V.
American Journal of Hospital Pharmacy 42(4): 784; 786
1985
ISSN/ISBN: 0002-9289 PMID: 3925766 Document Number: 265487
Document emailed within 1 workday
Related Documents
West, W.O. 1974: Specific indications for parenteral iron therapy--experience with one hundred patients using intravenous iron dextran Journal of the Kentucky Medical Association 72(11): 604-608Burns, D.L.; Mascioli, E.A.; Bistrian, B.R. 1995: Parenteral iron dextran therapy: a review Nutrition 11(2): 163-168
Niemiec, P.W.; Vanderveen, T.W.; Hohenwarter, M.W.; Gadsden, R.H. 1983: Stability of aminophylline injection in three parenteral nutrient solutions American Journal of Hospital Pharmacy 40(3): 428-432
Bhatt-Mehta, V.; Rosen, D.A.; King, R.S.; Maksym, C.J. 1993: Stability of midazolam hydrochloride in parenteral nutrient solutions American Journal of Hospital Pharmacy 50(2): 285-288
Condella, F.; Baptista, R.J.; Griffin, R.E. 1983: More efficient system for preparing total parenteral nutrient solutions American Journal of Hospital Pharmacy 40(12): 2146-2149
Fink, R.M. 1989: Spreadsheet program for neonatal and pediatric total parenteral nutrient solutions American Journal of Hospital Pharmacy 46(6): 1127-1128
Mo-Suwan, L.; Puetpaiboon, A.; Apiromrak, B. 1997: Calcium and phosphate solubility curves for parenteral nutrient solutions containing Vaminolact Journal of the Medical Association of Thailand 80(8): 516-520
Fitzgerald, K.A.; MacKay, M.W. 1987: Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF American Journal of Hospital Pharmacy 44(6): 1396-1400
Mikrut, B.A. 1987: Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF or TrophAmine American Journal of Hospital Pharmacy 44(12): 2702-2704
Savić, J.; Pantelić, D.; Vujnov, S.; Zunić, O. 1977: Study on the efficacy of dextran, gelatin and human albumin solutions as plasma substitutes Vojnosanitetski Pregled 34(3): 197-203
Geisser, P.; Hohl, H.; Baer, M.; Heim, H.; Fischer, W. 1991: Investigation on the dosage/efficacy relationship of iron dextran in veal calves Arzneimittel-Forschung 41(1): 32-37
Kumar, R.; Gulati, R.C.; Gupta, S.P. 1974: Plasma iron clearance after single-dose iron-dextran (Imferon) infusion in iron deficiency anaemia Indian Journal of Medical Research 62(7): 1039-1045
Mehta, B.C.; Jhaveri, K.; Patel, J.C. 1970: Total dose iron therapy using iron-dextran. a study of 514 cases using different techniques Indian Journal of Medical Sciences 24(4): 191-195
Muntané, J.; Puig-Parellada, P.; Mitjavila, M.T. 1995: Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine Journal of Laboratory and Clinical Medicine 126(5): 435-443
Anschel, J.; Mollica, J.A.; Lin, K.S. 1972: Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions Bulletin of the Parenteral Drug Association 26(6): 271-289
Burger, K.; Zay, I.; Takácsi Nagy, G.; Vértes, A.; Liptay, G.; Szepesi, G.; Wajand, J. 1985: A new polynuclear iron (III)-mixed ligand complex--for use in parenteral iron therapy Acta Pharmaceutica Hungarica 55(1): 37-45
Haliotis, F.A.; Papanastasiou, D.A. 1998: Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children International Journal of Clinical Pharmacology and Therapeutics 36(6): 320-325
Korbanka, R.; Schmitt, J. 1975: The use of dextran solutions Die Medizinische Welt 26(37): 1688
Fedele, F. 2003: DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. a multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine La Clinica Terapeutica 154(4): 231-236
Richter, W.; Hedin, H.; Messmer, K. 1980: Is hapten-inhibition effective in the infusion of dextran solutions? Der Anaesthesist 29(8): 444-445